E-Articles
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Diseases > Tuberculosis

Tags

  • involved
  • million
  • avian
  • developing combination
  • developing combination
  • avian influenza

  • Links

  • If You Move Yourself
  • Car Insurance for Teenagers - How to Get the Lowest Rate
  • Cameras and Fishing
  • E-Articles - Tuberculosis

    Bank-supported projects started in August 2004, when the Board of Directors approved a US$5 million emergency credit to
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    support Vietnam's National Action Plan for control of an avian influenza epidemic. In January 2006, the Board approved
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    the Global Program for Avian Influenza Control and Human Pandemic Preparedness and Response (GPAI). This new funding pr
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ogram of up to US$500 million allows countries to rapidly access funding to strengthen veterinarian and health services
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    to address outbreaks in animals, minimize the threat posed to people, and prepare for, and respond to potential human fl
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    u pandemic. The Kyrgyz Republic was the first to obtain US$4 million under the new financing framework. In March, the
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    Bank approved US$5.1 million for Azerbaijan as well as a US$50 million IDA credit for Nigeria to prepare for and respond
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    to avian influenza outbreaks. There are additional proposed avian influenza control projects for Turkey, Moldova, Georg
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ia, Nepal, Armenia, Albania, Bosnia-Herzegovina, Cambodia, Lao PDR, and Indonesia.

    Tuberculosis

    Tuberculosis is respon
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    sible for over 2 million deaths a year. It is a top cause of death among people who are HIV-positive, and is becoming m
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ore dangerous with the spread of drug-resistant strains. Bank staff contributed to the new Global Plan to Stop TB for 20
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    06-2015 that was launched at the 2006 World Economic Forum in Davos.

    We have financed TB control in over 30 countries,
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    mainly through the cost-effective Directly Observed Treatment, Short-Course (DOTS) Strategy which focuses on identifying
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    and curing infectious patients. Total investments reach now more than US$560 million and include ongoing large projects
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    in India and China – together home to over 40% of the world’s TB patients. Other Bank-supported operations include a US$
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    150 million loan to the Russian Federation for TB and AIDS control and a similar loan for US$60 million to Ukraine. (The
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    Ukraine operation was suspended as of August 22, 2006, pending agreed actions to restructure the operation).

    We are am
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ong the leaders in the Stop TB Partnership which now involves over 200 governments and organizations. In addition to dir
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ect support for TB control, the Bank is providing cross-cutting work on service delivery to improve the systems for cont
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    rolling TB and most Multi Country AIDS Program (MAP) operations (as in Eritrea, Kenya and Uganda) include a TB component


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-article.org.ua/article/241763/e-article-Tuberculosis.html">Tuberculosis</a>

    BB link (for phorums):
    [url=http://www.e-article.org.ua/article/241763/e-article-Tuberculosis.html]Tuberculosis[/url]

    Related Articles:

    My Product is Obviously Better - Why isn't it Selling?

    Uninstall Windows Media Player 10 and Start Enjoying Your Media Again

    Something Old, Something New

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com